Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - BIOCRYST PHARMACEUTICALS INC | f10k_022616p.htm |
| EX-10.70 - EXHIBIT 10.70 - BIOCRYST PHARMACEUTICALS INC | exh_1070.htm |
| EX-23 - EXHIBIT 23 - BIOCRYST PHARMACEUTICALS INC | exh_23.htm |
| EX-32.1 - EXHIBIT 32.1 - BIOCRYST PHARMACEUTICALS INC | exh_321.htm |
| EX-21 - EXHIBIT 21 - BIOCRYST PHARMACEUTICALS INC | exh_21.htm |
| EX-31.2 - EXHIBIT 31.2 - BIOCRYST PHARMACEUTICALS INC | exh_312.htm |
| EX-10.71 - EXHIBIT 10.71 - BIOCRYST PHARMACEUTICALS INC | exh_1071.htm |
| EX-31.1 - EXHIBIT 31.1 - BIOCRYST PHARMACEUTICALS INC | exh_311.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of BioCryst Pharmaceuticals, Inc. (the “Company”) on Form 10-K for the period ending December 31, 2015 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Thomas R. Staab, II, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
/s/ Thomas R. Staab II | |
|
Thomas R. Staab II Chief Financial Officer and Treasurer (Principal Financial Officer)
|
February 26, 2016
This certification is furnished with this Report on Form 10-K pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.